Information updated until 30/06/2026 CODE 98816 ACADEMIC YEAR 2026/2027 CREDITS 2.5 cfu anno 2 MEDICAL-PHARMACEUTICAL BIOTECHNOLOGY 11922 (LM-9 R) - GENOVA SCIENTIFIC DISCIPLINARY SECTOR BIO/14 LANGUAGE English TEACHING LOCATION GENOVA SEMESTER 2° Semester OVERVIEW Pharmacogenetics and pharmacogenomics are branches of pharmacology that study the genetic basis of individual variability in drug response. They are crucial for personalized medicine, an innovative approach aimed at optimizing drug treatments based on patient's individual characteristics, in order to better target therapies and reduce the risk of adverse reactions. AIMS AND CONTENT LEARNING OUTCOMES The aim of this course is to provide the students with knowledge about fundamental concepts of Pharmacogenomics and Pharmacogenetics. The course will be focused to study the changes of cellular and molecular mechanisms which regulate the different pharmacological responses. Moreover, the course will underline the most interesting progresses in therapy due to this new potential pharmacological approach and the possible future therapeutic development. AIMS AND LEARNING OUTCOMES The teaching aims to provide students with the necessary knowledge to understand the mechanisms by which genetic characteristics contribute to variability in drug response. In detail, the teaching aims to: - describe the impact of genetic polymorphisms on the expression and activity of drug targets, such as receptors, and of proteins involved in drug absorption, distribution, metabolism and excretion; - analyze the effects of genetic variability on the differences in drug responses within a population and the link with toxic effects or therapeutic inefficacy, with reference to specific diseases and their therapies - underline the importance of using pharmacogenetic tests in clinical practice for correct therapy design At the end, the student will be able to: - understand the relationship between genetic variability and variability in drug response, taking into account both polymorphisms in genes coding for proteins involved in pharmacokinetic processes and polymorphisms in genes coding for drug targets - recognize the impact of polymorphisms on the structure and activity of proteins involved in drug activity, highlighting their consequences at molecular and clinical levels - understand the importance of pharmacogenetics in personalized medicine - use scientific language appropriate to the discipline PREREQUISITES Knowledge of genetics, molecular biology and pharmacology is useful for a proper understanding of the topics TEACHING METHODS The course consists of 2.5 CFU, corresponding to 10 lectures of about two hours. During the lectures, students will be involved in discussions with questions and scientific reasoning to assess their level of knowledge and understanding of the topics covered. SYLLABUS/CONTENT Introduction to pharmacogenetics and pharmacogenomics: interindividual variability in drug response and personalized medicine. Genetic polymorphisms (single nucleotide polymorphisms, deletions, copy number variation) and possible impact on protein function. Polymorphisms in genes coding for proteins involved in drug metabolism: CYP2D6, CYP2C9, CYP2C19 and NAT-2 Polymorphisms in genes coding for proteins involved in drug transport: P-glycoprotein and OATP1B1 Polymorphisms in genes coding for drug target proteins: ß2 adrenergic receptors and asthma therapy; opioid receptors and pain therapy; serotonin transporter and depression therapy. HLA gene polymorphisms and adverse drug reactions. Examples of tools used in the clinic to highlight possible pharmacogenetic adverse drug reactions: ClinPGx Pharmacogenetics and precision medicine in cancer therapy. RECOMMENDED READING/BIBLIOGRAPHY The lecture slides covering the course programme will be made available on Aulaweb. These slides will also contain bibliographical references of articles in the scientific literature that will be discussed in class. TEACHERS AND EXAM BOARD GUENDALINA OLIVERO Ricevimento: The teacher is available by appointment (guendalina.olivero@unige.it). Exam Board GUENDALINA OLIVERO (President) TIZIANA BONIFACINO ANNA MARIA PITTALUGA LESSONS LESSONS START Classes will be held in the second semester; they will begin as timetable prepared by the competent Teaching Secretariat. The timetable for this course is available here: Portale EasyAcademy. Class schedule The timetable for this course is available here: Portale EasyAcademy EXAMS EXAM DESCRIPTION The examination will consist of an oral test. Students will be asked to prepare and discuss a powerpoint presentation on a topic related to the teaching. This will be the starting point for checking the level of preparation with regard to the topics addressed in the course. ASSESSMENT METHODS The final grade will be based on the level of preparation, reasoning abilities, the capacity to integrate and connect course topics, and the use of appropriate scientific language FURTHER INFORMATION Any Student with documented Specific Learning Disorders (SLD), or with any special needs, should contact the Lecturer and the dedicated SLD Representative in the Department before class begins, in order to decide the specific teaching methods so that the learning aims and outcomes may be met. Please contact the lecturer for further information. Agenda 2030 - Sustainable Development Goals Good health and well being Quality education Gender equality